Regulation and functions of sphingosine kinases in the brain

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1781, Issue 9, 2008, Pages 459-466

  Bryan, Lauren ^a   Kordula, Tomasz ^a   Spiegel, Sarah ^a   Milstien, Sheldon ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Central nervous system; Phosphorylation; Post translational modifications; Sphingosine kinase; Sphingsosine 1 phosphate; Transcription

Indexed keywords

ISOENZYME; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2;

BRAIN; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; GLIA CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID;

EUKARYOTA;

EID: 50049121874     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.04.008     Document Type: Review

References (109)

1. Spiegel S., and Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4 (2003) 397-407
2. Ogretmen B., and Hannun Y.A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4 (2004) 604-616
3. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind S., and Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381 (1996) 800-803
4. Hannun Y.A., and Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9 (2008) 139-150
5. Olivera A., and Spiegel S. Sphingosine-1-phosphate as a second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365 (1993) 557-560
6. Herr D.R., and Chun J. Effects of LPA and S1P on the nervous system and implications for their involvement in disease. Curr. Drug Targets 8 (2007) 155-167
7. Ishii I., Fukushima N., Ye X., and Chun J. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73 (2004) 321-354
8. Hla T., Lee M.J., Ancellin N., Paik J.H., and Kluk M.J. Lysophospholipids-receptor revelations. Science 294 (2001) 1875-1878
9. Hait N.C., Oskeritzian C.A., Paugh S.W., Milstien S., and Spiegel S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta 1758 (2006) 2016-2026
10. Mizugishi K., Yamashita T., Olivera A., Miller G.F., Spiegel S., and Proia R.L. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell Biol. 25 (2005) 11113-11121
11. Xia P., Gamble J.R., Wang L., Pitson S.M., Moretti P.A., Wattenberg B.W., D'Andrea R.J., and Vadas M.A. An oncogenic role of sphingosine kinase. Curr. Biol. 10 (2000) 1527-1530
12. Nava V.E., Hobson J.P., Murthy S., Milstien S., and Spiegel S. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp. Cell Res. 281 (2002) 115-127
13. French K.J., Schrecengost R.S., Lee B.D., Zhuang Y., Smith S.N., Eberly J.L., Yun J.K., and Smith C.D. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63 (2003) 5962-5969
14. Igarashi N., Okada T., Hayashi S., Fujita T., Jahangeer S., and Nakamura S.I. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J. Biol. Chem. 278 (2003) 46832-46839
15. Liu H., Toman R.E., Goparaju S., Maceyka M., Nava V.E., Sankala H., Payne S.G., Bektas M., Ishii I., Chun J., Milstien S., and Spiegel S. Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J. Biol. Chem. 278 (2003) 40330-40336
16. Liu H., Chakravarty D., Maceyka M., Milstien S., and Spiegel S. Sphingosine kinases: a novel family of lipid kinases. Prog. Nucl. Acid Res. 71 (2002) 493-511
17. Liu H., Sugiura M., Nava V.E., Edsall L.C., Kono K., Poulton S., Milstien S., Kohama T., and Spiegel S. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275 (2000) 19513-19520
18. Kohama T., Olivera A., Edsall L., Nagiec M.M., Dickson R., and Spiegel S. Molecular cloning and functional characterization of murine sphingosine kinase. J. Biol. Chem. 273 (1998) 23722-23728
19. Okada T., Ding G., Sonoda H., Kajimoto T., Haga Y., Khosrowbeygi A., Gao S., Miwa N., Jahangeer S., and Nakamura S. Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J. Biol. Chem. 280 (2005) 36318-36325
20. Sankala H.M., Hait N.C., Paugh S.W., Shida D., Lepine S., Elmore L.W., Dent P., Milstien S., and Spiegel S. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Res. 67 (2007) 10466-10474
21. Spiegel S., and Milstien S. Functions of the multifaceted family of sphingosine kinases and some close relatives. J. Biol. Chem. 282 (2007) 2125-2129
22. Alemany R., van Koppen C.J., Danneberg K., Ter Braak M., and Meyer Zu Heringdorf D. Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch. Pharmacol. 374 (2007) 413-428
23. Urtz N., Olivera A., Bofill-Cardona E., Csonga R., Billich A., Mechtcheriakova D., Bornancin F., Woisetschlager M., Rivera J., and Baumruker T. Early activation of sphingosine kinase in mast cells and recruitment to FcepsilonRI are mediated by its interaction with Lyn kinase. Mol. Cell Biol. 24 (2004) 8765-8777
24. Olivera A., and Rivera J. Sphingolipids and the balancing of immune cell function: lessons from the mast cell. J. Immunol. 174 (2005) 1153-1158
25. Olivera A., Edsall L., Poulton S., Kazlauskas A., and Spiegel S. Platelet-derived growth factor-induced activation of sphingosine kinase requires phosphorylation of the PDGF receptor tyrosine residue responsible for binding of PLCgamma. FASEB J. 13 (1999) 1593-1600
26. Sutherland C.M., Moretti P.A., Hewitt N.M., Bagley C.J., Vadas M.A., and Pitson S.M. The calmodulin-binding site of sphingosine kinase and its role in agonist-dependent translocation of sphingosine kinase 1 to the plasma membrane. J. Biol. Chem. 281 (2006) 11693-11701
27. Sarkar S., Maceyka M., Hait N.C., Paugh S.W., Sankala H., Milstien S., and Spiegel S. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett. 579 (2005) 5313-5317
28. Paugh B.S., Paugh S.W., Bryan L., Kapitonov D., Wilczynska K.M., Gopalan S.M., Rokita H., Milstien S., Spiegel S., and Kordula T. EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKC{delta}, and sphingosine kinase 1 in glioblastoma cells. FASEB J. 22 (2008) 455-465
29. Muracciole X., Romain S., Dufour H., Palmari J., Chinot O., Ouafik L., Grisoli F., Branger D.F., and Martin P.M. PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification. Int. J. Radiat. Oncol. Biol. Phys. 52 (2002) 592-598
30. Johnstone E.D., Mackova M., Das S., Payne S.G., Lowen B., Sibley C.P., Chan G., and Guilbert L.J. Multiple anti-apoptotic pathways stimulated by EGF in cytotrophoblasts. Placenta 26 (2005) 548-555
31. Yamanaka M., Shegogue D., Pei H., Bu S., Bielawska A., Bielawski J., Pettus B., Hannun Y.A., Obeid L., and Trojanowska M. Sphingosine kinase (SPHK1) is induced by TGF-beta and mediates TIMP-1 upregulation. J. Biol. Chem. 279 (2004) 53994-54001
32. Kono Y., Nishiuma T., Nishimura Y., Kotani Y., Okada T., Nakamura S., and Yokoyama M. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Am. J. Respir. Cell Mol. Biol. 37 (2007) 395-404
33. Rius R.A., Edsall L.C., and Spiegel S. Activation of sphingosine kinase in pheochromocytoma PC12 neuronal cells in response to trophic factors. FEBS Lett. 417 (1997) 173-176
34. Toman R.E., Payne S.G., Watterson K., Maceyka M., Lee N.H., Milstien S., Bigbee J.W., and Spiegel S. Differential transactivation of sphingosine-1-phosphate receptors modulates nerve growth factor-induced neurite extension. J. Cell Biol. 166 (2004) 381-392
35. Edsall L.C., Pirianov G.G., and Spiegel S. Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J. Neurosci. 17 (1997) 6952-6960
36. Patapoutian A., and Reichardt L.F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 11 (2001) 272-280
37. Shu X., Wu W., Mosteller R.D., and Broek D. Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol. Cell Biol. 22 (2002) 7758-7768
38. Johnson K.R., Becker K.P., Facchinetti M.M., Hannun Y.A., and Obeid L.M. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate. J. Biol. Chem. 277 (2002) 35257-35262
39. Pitson S.M., Moretti P.A., Zebol J.R., Lynn H.E., Xia P., Vadas M.A., and Wattenberg B.W. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 22 (2003) 5491-5500
40. Sharrocks A.D., Yang S.H., and Galanis A. Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem. Sci. 25 (2000) 448-453
41. Pitson S.M., Xia P., Leclercq T.M., Moretti P.A., Zebol J.R., Lynn H.E., Wattenberg B.W., and Vadas M.A. Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J. Exp. Med. 201 (2005) 49-54
42. Billich A., Bornancin F., Mechtcheriakova D., Natt F., Huesken D., and Baumruker T. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Cell Signal. 17 (2005) 1203-1217
43. Tsujimoto Y., Cossman J., Jaffe E., and Croce C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228 (1985) 1440-1443
44. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 (1998) 1322-1326
45. Taha T.A., Osta W., Kozhaya L., Bielawski J., Johnson K.R., Gillanders W.E., Dbaibo G.S., Hannun Y.A., and Obeid L.M. Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53. J. Biol. Chem. 279 (2004) 20546-20554
46. Bektas M., Jolly P.S., Muller C., Eberle J., Spiegel S., and Geilen C.C. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 24 (2005) 178-187
47. Li Q.F., Huang W.R., Duan H.F., Wang H., Wu C.T., and Wang L.S. Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells. Oncogene 26 (2007) 7904-7908
48. Sukocheva O.A., Wang L., Albanese N., Pitson S.M., Vadas M.A., and Xia P. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol. Endocrinol. 17 (2003) 2002-2012
49. Sukocheva O., Wadham C., Holmes A., Albanese N., Verrier E., Feng F., Bernal A., Derian C.K., Ullrich A., Vadas M.A., and Xia P. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J. Cell Biol. 173 (2006) 301-310
50. Doll F., Pfeilschifter J., and Huwiler A. Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration. Endocr. Relat. Cancer 14 (2007) 325-335
51. Olivera A., Urtz N., Mizugishi K., Yamashita Y., Gilfillan A.M., Furumoto Y., Gu H., Proia R.L., Baumruker T., and Rivera J. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J. Biol. Chem. 281 (2006) 2515-2525
52. Hait N.C., Sarkar S., Le Stunff H., Mikami A., Maceyka M., Milstien S., and Spiegel S. Role of sphingosine kinase 2 in cell migration towards epidermal growth factor. J. Biol. Chem. 280 (2005) 29462-29469
53. Hait N.C., Bellamy A., Milstien S., Kordula T., and Spiegel S. Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J. Biol. Chem. 282 (2007) 12058-12065
54. Ding G., Sonoda H., Yu H., Kajimoto T., Goparaju S.K., Jahangeer S., Okada T., and Nakamura S. Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2. J. Biol. Chem. 282 (2007) 27493-27502
55. Imamura T., Ohgane J., Ito S., Ogawa T., Hattori N., Tanaka S., and Shiota K. CpG island of rat sphingosine kinase-1 gene: tissue-dependent DNA methylation status and multiple alternative first exons. Genomics 76 (2001) 117-125
56. Imamura T., Miyauchi-Senda N., Tanaka S., and Shiota K. Identification of genetic and epigenetic similarities of SPHK1/Sphk1 in mammals. J. Vet. Med. Sci. 66 (2004) 1387-1393
57. Sobue S., Hagiwara K., Banno Y., Tamiya-Koizumi K., Suzuki M., Takagi A., Kojima T., Asano H., Nozawa Y., and Murate T. Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12. J. Neurochem. 95 (2005) 940-949
58. Nakade Y., Banno Y., T.K. K., Hagiwara K., Sobue S., Koda M., Suzuki M., Kojima T., Takagi A., Asano H., Nozawa Y., and Murate T. Regulation of sphingosine kinase 1 gene expression by protein kinase C in a human leukemia cell line, MEG-O1. Biochim. Biophys. Acta 1635 (2003) 104-116
59. Huwiler A., Doll F., Ren S., Klawitter S., Greening A., Romer I., Bubnova S., Reinsberg L., and Pfeilschifter J. Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-alpha-dependent mechanism. Biochim. Biophys. Acta 1761 (2006) 367-376
60. Murakami M., Ichihara M., Sobue S., Kikuchi R., Ito H., Kimura A., Iwasaki T., Takagi A., Kojima T., Takahashi M., Suzuki M., Banno Y., Nozawa Y., and Murate T. RET signaling-induced SPHK1 gene expression plays a role in both GDNF-induced differentiation and MEN2-type oncogenesis. J. Neurochem. 102 (2007) 1585-1594
61. Anelli V.V., Gault C.R., Cheng A.B., and Obeid L.M. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells: role of hypoxia-inducible factors 1 and 2. J. Biol. Chem. 283 (2008) 3365-3375
62. Edsall L.C., and Spiegel S. Enzymatic measurement of sphingosine 1-phosphate. Anal. Biochem. 272 (1999) 80-86
63. Tosaka M., Okajima F., Hashiba Y., Saito N., Nagano T., Watanabe T., Kimura T., and Sasaki T. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 32 (2001) 2913-2919
64. Van Brocklyn J.R., Jackson C.A., Pearl D.K., Kotur M.S., Snyder P.J., and Prior T.W. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J. Neuropathol. Exp. Neurol. 64 (2005) 695-705
65. Shinpo K., Kikuchi S., Moriwaka F., and Tashiro K. Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Res. 819 (1999) 170-173
66. Fukuda Y., Kihara A., and Igarashi Y. Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. Biochem. Biophys. Res. Commun. 309 (2003) 155-160
67. Blondeau N., Lai Y., Tyndall S., Popolo M., Topalkara K., Pru J.K., Zhang L., Kim H., Liao J.K., Ding K., and Waeber C. Distribution of sphingosine kinase activity and mRNA in rodent brain. J. Neurochem. 103 (2007) 509-517
68. Terada N., Banno Y., Ohno N., Fujii Y., Murate T., Sarna J.R., Hawkes R., Zea Z., Baba T., and Ohno S. Compartmentation of the mouse cerebellar cortex by sphingosine kinase. J. Comp. Neurol. 469 (2004) 119-127
69. Meno-Tetang G.M., Li H., Mis S., Pyszczynski N., Heining P., Lowe P., and Jusko W.J. Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses. Drug Metab. Dispos. 34 (2006) 1480-1487
70. Foster C.A., Howard L.M., Schweitzer A., Persohn E., Hiestand P.C., Balatoni B., Reuschel R., Beerli C., Schwartz M., and Billich A. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. J. Pharmacol. Exp. Ther. 323 (2007) 469-475
71. Baumruker T., Billich A., and Brinkmann V. FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis. Expert Opin. Investig. Drugs 16 (2007) 283-289
72. Bassi R., Anelli V., Giussani P., Tettamanti G., Viani P., and Riboni L. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through G(i)-protein-coupled receptors. Glia 53 (2006) 621-630
73. Kajimoto T., Okada T., Yu H., Goparaju S.K., Jahangeer S., and Nakamura S. Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. Mol. Cell Biol. 27 (2007) 3429-3440
74. Tornquist K., Saarinen P., Vainio M., and Ahlstrom M. Sphingosine 1-phosphate mobilizes sequestered calcium, activates calcium entry, and stimulates deoxyribonucleic acid synthesis in thyroid k. Endocrinology 138 (1997) 4049-4057
75. Titievsky A., Titievskaya I., Pasternack M., Kaila K., and Tornquist K. Sphingosine inhibits voltage-operated calcium channels in GH4C1 cells. J. Biol. Chem. 273 (1998) 242-247
76. Blom T., Bergelin N., Slotte J.P., and Tornquist K. Sphingosine kinase regulates voltage operated calcium channels in GH4C1 rat pituitary cells. Cell Signal. 18 (2006) 1366-1375
77. Fujita T., Okada T., Hayashi S., Jahangeer S., Miwa N., and Nakamura S. Delta-catenin/NPRAP (neural plakophilin-related armadillo repeat protein) interacts with and activates sphingosine kinase 1. Biochem. J. 382 (2004) 717-723
78. Van Brocklyn J.R., Young N., and Roof R. Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells. Cancer Lett. 199 (2003) 53-60
79. Young N., and Van Brocklyn J.R. Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P(2) on cell migration and invasiveness. Exp. Cell Res. 313 (2007) 1615-16127
80. MacLennan A.J., Carney P.R., Zhu W.J., Chaves A.H., Garcia J., Grimes J.R., Anderson K.J., Roper S.N., and Lee N. An essential role for the H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. Eur. J. Neurosci. 14 (2001) 203-209
81. Maclennan A.J., Benner S.J., Andringa A., Chaves A.H., Rosing J.L., Vesey R., Karpman A.M., Cronier S.A., Lee N., Erway L.C., and Miller M.L. The S1P(2) sphingosine 1-phosphate receptor is essential for auditory and vestibular function. Hear. Res. 220 (2006) 38-48
82. Herr D.R., Grillet N., Schwander M., Rivera R., Muller U., and Chun J. Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2. J. Neurosci. 27 (2007) 1474-1478
83. Kono M., Belyantseva I.A., Skoura A., Frolenkov G.I., Starost M.F., Dreier J.L., Lidington D., Bolz S.S., Friedman T.B., Hla T., and Proia R.L. Deafness and stria vascularis defects in S1P2 receptor null mice. J. Biol. Chem. 282 (2007) 10690-10696
84. Zhang Y.H., Vasko M.R., and Nicol G.D. Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons. J. Physiol. 575 (2006) 101-113
85. Zhang Y.H., Fehrenbacher J.C., Vasko M.R., and Nicol G.D. Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons. J. Neurophysiol. 96 (2006) 1042-1052
86. Kimura A., Ohmori T., Ohkawa R., Madoiwa S., Mimuro J., Murakami T., Kobayashi E., Hoshino Y., Yatomi Y., and Sakata Y. Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. Stem Cells 25 (2007) 115-124
87. Yu N., Lariosa-Willingham K.D., Lin F.F., Webb M., and Rao T.S. Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes. Glia 45 (2004) 17-27
88. Saini H.S., Coelho R.P., Goparaju S.K., Jolly P.S., Maceyka M., Spiegel S., and Sato-Bigbee C. Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. J. Neurochem. 95 (2005) 1298-1310
89. Jaillard C., Harrison S., Stankoff B., Aigrot M.S., Calver A.R., Duddy G., Walsh F.S., Pangalos M.N., Arimura N., Kaibuchi K., Zalc B., and Lubetzki C. Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J. Neurosci. 25 (2005) 1459-1469
90. Novgorodov A.S., El-Alwani M., Bielawski J., Obeid L.M., and Gudz T.I. Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J. 21 (2007) 1503-1514
91. Jung C.G., Kim H.J., Miron V.E., Cook S., Kennedy T.E., Foster C.A., Antel J.P., and Soliven B. Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia 55 (2007) 1656-1667
92. Kappos L., Antel J., Comi G., Montalban X., O'Connor P., Polman C.H., Haas T., Korn A.A., Karlsson G., and Radue E.W. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N. Engl. J. Med. 355 (2006) 1124-1140
93. Allende M.L., Sasaki T., Kawai H., Olivera A., Mi Y., van Echten-Deckert G., Hajdu R., Rosenbach M., Keohane C.A., Mandala S., Spiegel S., and Proia R.L. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279 (2004) 52487-52492
94. Kharel Y., Lee S., Snyder A.H., Sheasley-O'neill L., S., Morris M.A., Setiady Y., Zhu R., Zigler M.A., Burcin T.L., Ley K., Tung K.S., Engelhard V.H., Macdonald T.L., and Lynch K.R. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J. Biol. Chem. 280 (2005) 36865-36872
95. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., Allende M.L., Proia R.L., and Cyster J.G. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004) 355-360
96. Graler M.H., and Goetzl E.J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors. FASEB J. 18 (2004) 551-553
97. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23 (2005) 127-159
98. Coelho R.P., Payne S.G., Bittman R., Spiegel S., and Sato-Bigbee C. The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J. Pharmacol. Exp. Ther. 323 (2007) 626-635
99. Rao T.S., Lariosa-Willingham K.D., Lin F.F., Palfreyman E.L., Yu N., Chun J., and Webb M. Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes. Brain Res. 990 (2003) 182-194
100. Mullershausen F., Craveiro L.M., Shin Y., Cortes-Cros M., Bassilana F., Osinde M., Wishart W.L., Guerini D., Thallmair M., Schwab M.E., Sivasankaran R., Seuwen K., and Dev K.K. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. J. Neurochem. 102 (2007) 1151-1161
101. Anelli V., Bassi R., Tettamanti G., Viani P., and Riboni L. Extracellular release of newly synthesized sphingosine-1-phosphate by cerebellar granule cells and astrocytes. J. Neurochem. 92 (2005) 1204-1215
102. Sato K., Ishikawa K., Ui M., and Okajima F. Sphingosine 1-phosphate induces expression of early growth response-1 and fibroblast growth factor-2 through mechanism involving extracellular signal-regulated kinase in astroglial cells. Brain Res. Mol. Brain Res. 74 (1999) 182-189
103. Sorensen S.D., Nicole O., Peavy R.D., Montoya L.M., Lee C.J., Murphy T.J., Traynelis S.F., and Hepler J.R. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol. Pharmacol. 64 (2003) 1199-1209
104. Tham C.S., Lin F.F., Rao T.S., Yu N., and Webb M. Microglial activation state and lysophospholipid acid receptor expression. Int. J. Dev. Neurosci. 21 (2003) 431-443
105. Sato K., Ui M., and Okajima F. Differential roles of Edg-1 and Edg-5, sphingosine 1-phosphate receptors, in the signaling pathways in C6 glioma cells. Brain Res. Mol. Brain Res. 85 (2000) 151-160
106. Osinde M., Mullershausen F., and Dev K.K. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology 52 (2007) 1210-1218
107. Lepley D., Paik J.H., Hla T., and Ferrer F. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res. 65 (2005) 3788-3795
108. Malchinkhuu E., Sato K., Maehama T., Mogi C., Tomura H., Ishiuchi S., Yoshimoto Y., Kurose H., and Okajima F. S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. Biochem. Biophys. Res. Commun. 366 (2007) 963-968
109. Kim K., Kim Y.L., Sacket S.J., Kim H.L., Han M., Park D.S., Lee B.K., Lee W.K., Ha H.J., and Im D.S. Sphingosine 1-phosphate (S1P) induces shape change in rat C6 glioma cells through the S1P2 receptor: development of an agonist for S1P receptors. J. Pharm. Pharmacol. 59 (2007) 1035-1041